Investment strategy
The BioScience Ventures Group focuses on investing in early stage life science companies in Germany, Austria and Switzerland that due to their outstanding technology can satisfy unmet medical needs in the fields of pharmaceuticals, biotechnology, and medical technology (medical devices).

The Management team should be as competitive as their technology. Our initial investment averages EUR 250.000 to EUR 500.000 and we try to help our companies to accelerate the preclinical and clinical trials as well as to reduce costs of development by intensive consultancy.

Additionally we help our companies in business concerns e.g. fundraising. We seek companies to address unmet medical needs in not only large markets. We always want to be actively involved by taking a seat in the company board.

© copyright The BioScience Ventures Group 2010